Clinical Trial Update: Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating low-dose ticagrelor with standard-dose clopidogrel on platelet reactivity in Chinese patients with stable coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Platelet Reactivity | Phase 4 | Status: COMPLETED